Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate for Cyclic Vomiting Syndrome in Children
NCT00286988Phase 4Terminated
- Start
- Mar 2006
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of topiramate in cyclic vomiting syndrome (CVS). Primary endpoint: Reduction of cycle frequency. Started Mar 2006; status: terminated.
02
Drugs
topiramate
03
Conditions
cyclic vomiting syndrome (CVS)
Beyond the preview
Go deeper on NCT00286988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00286988.